搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Sulfolobus solfataricus Tryptophan--tRNA ligase (trpS) CSB-YP857234FPM
CSB-EP857234FPM
CSB-BP857234FPM
CSB-MP857234FPM
CSB-EP857234FPM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus solfataricus Non-canonical purine NTP pyrophosphatase (SSO0432) CSB-YP857235FPM
CSB-EP857235FPM
CSB-BP857235FPM
CSB-MP857235FPM
CSB-EP857235FPM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus solfataricus 30S ribosomal protein S15P/S13e (rps15p) CSB-YP857236FPM
CSB-EP857236FPM
CSB-BP857236FPM
CSB-MP857236FPM
CSB-EP857236FPM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus solfataricus Probable molybdenum cofactor biosynthesis protein A (moaA) CSB-YP857237FPM
CSB-EP857237FPM
CSB-BP857237FPM
CSB-MP857237FPM
CSB-EP857237FPM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus solfataricus Probable 3-phosphoshikimate 1-carboxyvinyltransferase (aroA) CSB-YP857238FPM
CSB-EP857238FPM
CSB-BP857238FPM
CSB-MP857238FPM
CSB-EP857238FPM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus solfataricus 7-cyano-7-deazaguanine tRNA-ribosyltransferase (tgtA), partial CSB-YP857239FPM
CSB-EP857239FPM
CSB-BP857239FPM
CSB-MP857239FPM
CSB-EP857239FPM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus solfataricus UPF0215 protein SSO0256 (SSO0256) CSB-YP857240FPM
CSB-EP857240FPM
CSB-BP857240FPM
CSB-MP857240FPM
CSB-EP857240FPM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus solfataricus Probable translation initiation factor IF-2 (infB), partial CSB-YP857241FPM
CSB-EP857241FPM
CSB-BP857241FPM
CSB-MP857241FPM
CSB-EP857241FPM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus solfataricus Probable deoxycytidine triphosphate deaminase (dcd) CSB-YP857242FPM
CSB-EP857242FPM
CSB-BP857242FPM
CSB-MP857242FPM
CSB-EP857242FPM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus solfataricus Aspartate--tRNA ligase (aspS) CSB-YP857243FPM
CSB-EP857243FPM
CSB-BP857243FPM
CSB-MP857243FPM
CSB-EP857243FPM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus solfataricus Acetylglutamate/acetylaminoadipate kinase (argB) CSB-YP857244FPM
CSB-EP857244FPM
CSB-BP857244FPM
CSB-MP857244FPM
CSB-EP857244FPM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus solfataricus Phosphoribosylglycinamide formyltransferase 2 (purT) CSB-YP857245FPM
CSB-EP857245FPM
CSB-BP857245FPM
CSB-MP857245FPM
CSB-EP857245FPM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium loti D-amino acid dehydrogenase 3 small subunit (dadA3) CSB-YP857246RCU
CSB-EP857246RCU
CSB-BP857246RCU
CSB-MP857246RCU
CSB-EP857246RCU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Molluscum contagiosum virus subtype 1 Early transcription factor 82 kDa subunit (VETFL), partial CSB-YP857247MHI
CSB-EP857247MHI
CSB-BP857247MHI
CSB-MP857247MHI
CSB-EP857247MHI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium loti N-acetyl-gamma-glutamyl-phosphate reductase (argC) CSB-YP857248RCU
CSB-EP857248RCU
CSB-BP857248RCU
CSB-MP857248RCU
CSB-EP857248RCU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium loti N utilization substance protein B homolog (nusB) CSB-YP857249RCU
CSB-EP857249RCU
CSB-BP857249RCU
CSB-MP857249RCU
CSB-EP857249RCU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium loti Isoleucine--tRNA ligase (ileS), partial CSB-YP857250RCU
CSB-EP857250RCU
CSB-BP857250RCU
CSB-MP857250RCU
CSB-EP857250RCU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium loti Molybdopterin synthase catalytic subunit (moaE) CSB-YP857251RCU
CSB-EP857251RCU
CSB-BP857251RCU
CSB-MP857251RCU
CSB-EP857251RCU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium loti 50S ribosomal protein L9 (rplI) CSB-YP857252RCU
CSB-EP857252RCU
CSB-BP857252RCU
CSB-MP857252RCU
CSB-EP857252RCU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhizobium loti DNA repair protein recO (recO) CSB-YP857253RCU
CSB-EP857253RCU
CSB-BP857253RCU
CSB-MP857253RCU
CSB-EP857253RCU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>